Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Rigotti

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2018
Interleukin-27 is a potential marker for the onset of post-transplant malignanciesPaola Pontrelli, Federica Rascio, Gianluigi Zaza, et al.
Transplantation|December 6, 2003
Incidence of cancer after kidney transplant: results from the North Italy transplant programPaola Pedotti, Massimo Cardillo, Giuseppe Rossini, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 24, 2019
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodiesDenis Glotz, Graeme Russ, Lionel Rostaing, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 22, 2006
12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipientsHelio Tedesco-Silva, Stefan Vitko, Julio Pascual, et al.
Oncogenesis|June 20, 2018
Effects of immune suppression for transplantation on inflammatory colorectal cancer progressionImerio Angriman, Lucrezia Furian, Melania Scarpa, et al.
Oncogenesis|August 2, 2018
Correction: Effects of immune suppression for transplantation on inflammatory colorectal cancer progressionImerio Angriman, Lucrezia Furian, Melania Scarpa, et al.
Endocrine|July 2, 2015
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteinsMaria Fusaro, Sandro Giannini, Maurizio Gallieni, et al.
Journal of Clinical Medicine|November 9, 2024
Surgery or Comorbidities: What Is the Primum Movens of Kidney Dysfunction After Nephrectomy? A Multicenter Study in Living Donors and Cancer PatientsFrancesco Trevisani, Matteo Floris, Francesco Trepiccione, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2012
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009Pierluca Piselli, Diego Serraino, Giuseppe Paolo Segoloni, et al.
Lancet (London, England)|August 11, 2004
Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trialGiuseppe Remuzzi, Mariadomenica Lesti, Eliana Gotti, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2018
Interleukin-27 is a potential marker for the onset of post-transplant malignanciesPaola Pontrelli, Federica Rascio, Gianluigi Zaza, et al.
Transplantation|December 6, 2003
Incidence of cancer after kidney transplant: results from the North Italy transplant programPaola Pedotti, Massimo Cardillo, Giuseppe Rossini, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 24, 2019
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodiesDenis Glotz, Graeme Russ, Lionel Rostaing, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 22, 2006
12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipientsHelio Tedesco-Silva, Stefan Vitko, Julio Pascual, et al.
Oncogenesis|June 20, 2018
Effects of immune suppression for transplantation on inflammatory colorectal cancer progressionImerio Angriman, Lucrezia Furian, Melania Scarpa, et al.
Oncogenesis|August 2, 2018
Correction: Effects of immune suppression for transplantation on inflammatory colorectal cancer progressionImerio Angriman, Lucrezia Furian, Melania Scarpa, et al.
Endocrine|July 2, 2015
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteinsMaria Fusaro, Sandro Giannini, Maurizio Gallieni, et al.
Journal of Clinical Medicine|November 9, 2024
Surgery or Comorbidities: What Is the Primum Movens of Kidney Dysfunction After Nephrectomy? A Multicenter Study in Living Donors and Cancer PatientsFrancesco Trevisani, Matteo Floris, Francesco Trepiccione, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2012
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009Pierluca Piselli, Diego Serraino, Giuseppe Paolo Segoloni, et al.
Lancet (London, England)|August 11, 2004
Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trialGiuseppe Remuzzi, Mariadomenica Lesti, Eliana Gotti, et al.
Pageof 9